Chemed Corporation
CHE | NYSE
$540.58
+$5.86 (+1.10%)
Nov 2, 2026, 12:39 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.53B | 2.43B | 2.26B | 2.13B | 2.14B | 2.08B |
Cost of Revenue | 1.77B | 1.58B | 1.47B | 1.37B | 1.37B | 1.38B |
Gross Profit | 758.34M | 854.35M | 798.82M | 765.09M | 769.8M | 701.39M |
Operating Income | 338.25M | 366.49M | 340.57M | 343.5M | 343.04M | 389.68M |
Interest Income | 8.75M | 14.61M | 6.27M | 355K | 377K | 757K |
Pretax Income | 355.78M | 399.47M | 350.37M | 329.68M | 350.31M | 395.99M |
Net Income | 265.24M | 302M | 272.51M | 249.62M | 268.55M | 319.47M |
Selling & General & Admin | 417.19M | 424.36M | 395.12M | 358.73M | 366.73M | 330.22M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 63.5M | 63.13M | 62.86M | 60.04M | -18.51M |
Operating Expenses | 417.19M | 487.86M | 458.25M | 421.59M | 426.77M | 311.71M |
Interest Expense | 1.75M | 1.78M | 3.11M | 4.58M | 1.87M | 2.36M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.19B | 2.06B | 1.92B | 1.79B | 1.8B | 1.69B |
Income Tax Expense | 90.54M | 97.47M | 77.86M | 80.06M | 81.76M | 76.52M |
Shares Outstanding (Basic) | 14.4M | 15.02M | 15.05M | 14.93M | 15.67M | 15.96M |
Shares Outstanding (Diluted) | 14.4M | 15.19M | 15.2M | 15.1M | 15.94M | 16.4M |
EPS (Basic) | 18.42 | 20.10 | 18.11 | 16.72 | 17.14 | 20.02 |
EPS (Diluted) | 18.42 | 19.89 | 17.93 | 16.53 | 16.85 | 19.48 |
EBITDA | 422.37M | 464.29M | 414.34M | 393.44M | 411.23M | 454.93M |
EBIT | 357.53M | 401.25M | 353.48M | 334.26M | 352.18M | 398.35M |
Depreciation & Amortization | 64.84M | 63.05M | 60.87M | 59.17M | 59.05M | 56.58M |
Add to Watchlist
Select watchlists to add or remove CHE